Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Website

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE-300760

Basic

  • Market Cap

    CN¥326.29B

  • EV

    CN¥305.64B

  • Shares Out

    1,209.39M

  • Revenue

    CN¥35.94B

  • Employees

    18,044

Margins

  • Gross

    65.35%

  • EBITDA

    37.78%

  • Operating

    35.32%

  • Pre-Tax

    38.07%

  • Net

    33.86%

  • FCF

    27.9%

Returns (5Yr Avg)

  • ROA

    23.06%

  • ROTA

    34.84%

  • ROE

    32.78%

  • ROCE

    32.51%

  • ROIC

    47.55%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CN¥391.18

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    CN¥21.19B

  • Net Debt

    -CN¥20.91B

  • Debt/Equity

    0.01

  • EBIT/Interest

    854.1

Growth (CAGR)

  • Rev 3Yr

    17.66%

  • Rev 5Yr

    20.03%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    20.03%

  • Dil EPS 5Yr

    24.02%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    19.45%

  • EBITDA Fwd 2Yr

    17.04%

  • EPS Fwd 2Yr

    19.95%

  • EPS LT Growth Est

    18.5%

Dividends

  • Yield

    —

  • Payout

    57.75%

  • DPS

    CN¥5.8

  • DPS Growth 3Yr

    32.38%

  • DPS Growth 5Yr

    42.13%

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    132.27%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Jan '22

Jan '23

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Jan '22
Jan '23
Dec '23
LTM

Operating Revenues

16,519.6

20,981

25,257.8

30,353.8

34,875.3

35,883.8

Other Revenues, Total

36.4

44.9

11.7

11.8

56.6

56.6

Total Revenues

16,556

21,025.8

25,269.6

30,365.6

34,931.9

35,940.4

Total Revenues % Chg.

—

20.4%

27%

20.2%

20.2%

15%

13.1%

Cost of Goods Sold, Total

5,799.2

7,459.5

8,967

10,955.6

12,075.3

12,454.7

Gross Profit

10,756.8

13,566.4

16,302.6

19,410

22,856.6

23,485.7

Selling General & Admin Expenses, Total

4,370.7

4,509.1

5,104.6

6,121.6

7,226.7

7,354.6

Provision for Bad Debts

8.8

29.7

-6.7

37.1

244.6

263.7

R&D Expenses

—

—

—

1,465.6

1,869.3

2,524.2

2,922.6

3,432.7

3,527.8

Other Operating Expenses

-81.8

-100.8

-83.1

-80.4

-308.8

-353.2

Other Operating Expenses, Total

5,763.3

6,307.2

7,539

9,001

10,595.1

10,792.9

Operating Income

4,993.5

7,259.1

8,763.6

10,409

12,261.5

12,692.8

Interest Expense, Total

—

—

-8.6

-10.7

-13

-14.9

Interest And Investment Income

331.3

385.7

408.1

357.9

821.6

873

Net Interest Expenses

331.3

385.7

399.5

347.2

808.6

858.1

Income (Loss) On Equity Invest.

—

—

—

—

—

—

-4.5

—

—

—

-2

Currency Exchange Gains (Loss)

156.3

-253.4

-227.7

172

119.2

119.2

Other Non Operating Income (Expenses)

-79.7

-70.9

-85.9

-67.8

-72.5

-6.6

EBT, Excl. Unusual Items

5,401.4

7,316.1

8,849.5

10,860.4

13,116.8

13,661.5

Impairment of Goodwill

—

—

—

—

-94.5

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

9.9

-26.4

69.6

195.6

Gain (Loss) On Sale Of Assets

-1.5

-2.1

4.1

6.2

2.5

2.7

Asset Writedown

-18.1

-16.9

-7.5

-0.7

-274.9

-275.8

Legal Settlements

2.4

-2.4

-5.7

-3.3

-12.6

-12.6

Other Unusual Items

78.5

143.7

166.8

117.5

109.7

109.7

EBT, Incl. Unusual Items

5,368.3

7,438.4

9,017.1

10,953.6

13,010.9

13,681

Income Tax Expense

683.4

778.8

1,013

1,342.8

1,432.5

1,513.2

Earnings From Continuing Operations

4,684.8

6,659.6

8,004

9,610.7

11,578.4

12,167.9

Minority Interest

-4.2

-1.9

-2.5

-3.5

3.8

3.1

Net Income

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,171

Net Income to Common Incl Extra Items

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,171

Net Income to Common Excl. Extra Items

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,171

Total Shares Outstanding

1,215.7

1,215.7

1,212.6

1,209.4

1,214.2

1,210.4

Weighted Avg. Shares Outstanding

1,215.7

1,215.7

1,214.8

1,209.9

1,211.7

1,212

Weighted Avg. Shares Outstanding Dil

1,215.7

1,215.7

1,214.8

1,210.4

1,211.8

1,212.1

EPS

3.9

5.5

6.6

7.9

9.6

10

EPS Diluted

3.9

5.5

6.6

7.9

9.6

10

EBITDA

5,387.8

7,731.3

9,380.1

11,188.1

13,125.9

13,578.6

Effective Tax Rate

12.7%

10.5%

11.2%

12.3%

11%

11.1%